1800-272-662
Shopping Cart 0
countryflagAU
Login

Cryosite Ltd

Healthcare AU CTE

1.195AUD
-(-%)

Last update at 2026-03-13T02:14:00Z

Day Range

1.201.20
LowHigh

52 Week Range

0.661.30
LowHigh

Fundamentals

  • Previous Close 1.20
  • Market Cap58.33M
  • Volume31
  • P/E Ratio29.88
  • Dividend Yield-%
  • EBITDA3.44M
  • Revenue TTM15.75M
  • Revenue Per Share TTM0.32
  • Gross Profit TTM 9.73M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 2.52M 2.09M 1.57M 1.81M 1.12M
Minority interest - - - - -
Net income 1.88M 1.84M 1.41M 1.36M 0.65M
Selling general administrative 5.47M 5.11M 4.90M 4.29M 4.17M
Selling and marketing expenses 0.06M 0.05M 0.06M 0.09M 0.07M
Gross profit 8.89M 7.99M 7.17M 6.84M 5.89M
Reconciled depreciation 0.87M 0.79M 0.70M 0.56M 0.59M
Ebit 2.54M 2.25M 1.60M 1.84M 1.06M
Ebitda 3.41M 3.04M 2.30M 2.40M 1.65M
Depreciation and amortization 0.87M 0.79M 0.70M 0.56M 0.59M
Non operating income net other - - - - -
Operating income 2.50M 2.05M 1.52M 1.88M 1.21M
Other operating expenses 11.62M 10.56M 0.89M 0.04M 0.54M
Interest expense 0.02M 0.16M 0.03M 0.03M 0.10M
Tax provision 0.64M 0.25M 0.17M 0.44M 0.47M
Interest income 0.18M 0.20M 0.08M 0.00700M 0.00819M
Net interest income 0.03M 0.03M 0.05M -0.07433M 0.00819M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.64M 0.25M 0.17M 0.44M 0.47M
Total revenue 14.12M 12.61M 11.94M 11.76M 10.02M
Total operating expenses 6.39M 5.94M 5.65M 4.95M 4.83M
Cost of revenue 5.23M 4.62M 4.76M 4.92M 4.13M
Total other income expense net 0.03M 0.03M 0.05M -0.01131M 0.05M
Discontinued operations - - - - -
Net income from continuing ops 1.88M 1.84M 1.41M 1.36M 0.65M
Net income applicable to common shares 1.88M 1.84M 1.41M 1.36M 0.65M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 19.46M 19.71M 22.65M 21.50M 21.99M
Intangible assets - - 0.00800M 0.01M 0.02M
Earning assets - - - - -
Other current assets 1.04M 0.44M 1.20M 1.25M 1.30M
Total liab 17.07M 18.26M 19.86M 19.64M 21.62M
Total stockholder equity 2.39M 1.45M 2.78M 1.86M 0.38M
Deferred long term liab - - 8.16M 9.35M 10.60M
Other current liab 2.09M 1.06M 0.94M 0.80M 0.45M
Common stock - 3.54M 5.98M 5.98M 5.86M
Capital stock 3.54M - 5.98M 5.98M 5.86M
Retained earnings -1.18100M -2.08900M -3.19700M -4.11785M -5.51464M
Other liab - - 13.64M 15.30M 17.29M
Good will - - - - -
Other assets - - 9.42M 10.78M 12.53M
Cash 5.06M 4.70M 5.73M 5.34M 3.88M
Cash and equivalents - - 5.73M 5.34M 3.88M
Total current liabilities 4.53M 3.99M 3.78M 3.73M 3.48M
Current deferred revenue - 2.10M 2.04M 2.23M 2.19M
Net debt - -2.25800M -3.12500M -4.49125M -2.81611M
Short term debt - 0.18M 0.16M 0.23M 0.22M
Short long term debt - - - - -
Short long term debt total - 2.44M 2.61M 0.85M 1.07M
Other stockholder equity - - -2.78200M - -0.34715M
Property plant equipment - - 4.04M 2.29M 2.04M
Total current assets 8.87M 6.61M 9.18M 8.30M 7.29M
Long term investments - - - - -
Net tangible assets - - 2.68M 1.74M 0.25M
Short term investments - - 1.00M - -
Net receivables 2.15M 1.41M 1.73M 1.21M 1.67M
Long term debt - - - - -
Inventory 0.04M 0.06M 0.06M 0.05M 0.05M
Accounts payable 1.07M 0.66M 0.63M 0.46M 0.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - 0.03M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.19M 8.36M 8.36M 9.52M 10.79M
Deferred long term asset charges - - - - -
Non current assets total 10.60M 13.10M 13.47M 13.20M 14.70M
Capital lease obligations 2.27M - 2.61M 0.85M 1.07M
Long term debt total - - 2.44M 0.62M 0.85M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.42000M 0.73M -1.22300M -0.86025M -0.37408M
Change to liabilities - - -1.30500M -1.31251M -1.33069M
Total cashflows from investing activities -0.42000M 0.73M -1.22300M -0.86025M -0.37408M
Net borrowings - - -0.28000M -0.29258M -0.26078M
Total cash from financing activities -1.28700M -3.49800M -0.79600M -0.18066M -0.29542M
Change to operating activities - - 1.18M 1.33M 1.43M
Net income 1.88M 1.84M 1.41M 1.36M 0.65M
Change in cash 0.36M -0.02800M -0.61000M 1.46M -0.18071M
Begin period cash flow 4.70M 4.73M 5.34M 3.88M 4.06M
End period cash flow 5.06M 4.70M 4.73M 5.34M 3.88M
Total cash from operating activities 2.06M 2.74M 1.41M 2.52M 0.52M
Issuance of capital stock - - - 0.12M -
Depreciation - 0.79M 0.65M 0.53M 0.56M
Other cashflows from investing activities 0.17M 0.18M 0.08M 0.00294M 0.02M
Dividends paid -0.97600M -0.73200M 0.49M 0.49M 0.49M
Change to inventory - - - - -
Change to account receivables - 0.34M -0.53000M 0.47M -0.97410M
Sale purchase of stock - -2.44100M - 0.12M 0.00000M
Other cashflows from financing activities -0.31100M -0.32500M -0.30800M -0.29766M -0.29542M
Change to netincome - - -0.04000M 0.11M 0.13M
Capital expenditures 0.59M 0.45M 0.30M 0.86M 0.40M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 0.15M -0.53000M 0.47M -0.97410M
Stock based compensation - - - 0.00256M 0.01M
Other non cash items 2.06M 2.60M -0.11900M 0.63M -0.69464M
Free cash flow 1.48M 2.44M 1.11M 1.66M 0.12M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CTE
Cryosite Ltd		 - -% 1.20 29.88 10.47 3.70 16.16 4.10 16.61
SHL
Sonic Healthcare Ltd		 0.09 0.43% 21.20 19.10 15.48 1.01 1.22 1.52 8.99
IDX
Integral Diagnostics Ltd		 0.01 0.43% 2.32 57.75 15.80 1.12 1.30 1.89 12.08
HLS
Healius Ltd		 - -% 0.59 - 26.25 0.32 0.78 0.96 10.14
ACL
Australian Clinical Labs Ltd		 -0.02 0.97% 2.05 14.79 12.17 0.54 2.75 0.96 3.92

Reports Covered

Stock Research & News

View All

Profile

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Cryosite Ltd

13a Ferndell Street, South Granville, NSW, Australia, 2142

Key Executives

Name Title Year Born
Mr. John Hogg Chief Exec. Officer NA
Ms. Jane Hao Chief Financial Officer NA
Ms. Kim Bradley-Ware B.Com., CPA, L.L.B. Company Sec. NA
Mr. John Hogg CMILT CEO, MD & Director NA
Mr. Jon Stearns Operations Manager NA
Ms. Alicia Steel Chief Quality Officer NA
Mr. Dray Andrea Company Secretary NA
Mr. John Hogg CMILT CEO, MD & Director NA
Mr. Jon Stearns Operations Manager NA
Ms. Alicia Steel Chief Quality Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.